- Home
- EXEL vs ATR Comparison
EXEL vs ATR Comparison
Compare EXEL & ATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXEL | ATR |
|---|---|---|
| Founded | 1994 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Plastic Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 9.3B |
| IPO Year | 2000 | 1995 |
Fundamental Metrics
Financial Performance| Metric | EXEL | ATR |
|---|---|---|
| Price | $43.96 | $145.16 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 4 |
| Target Price | $46.60 | ★ $167.50 |
| AVG Volume (30 Days) | ★ 2.6M | 598.1K |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.32% |
| EPS Growth | ★ 57.95 | 6.51 |
| EPS | 2.78 | ★ 5.89 |
| Revenue | $452,477,000.00 | ★ $3,777,181,000.00 |
| Revenue This Year | $13.66 | $5.29 |
| Revenue Next Year | $14.30 | $4.98 |
| P/E Ratio | ★ $15.69 | $24.63 |
| Revenue Growth | N/A | ★ 5.42 |
| 52 Week Low | $32.38 | $103.23 |
| 52 Week High | $48.74 | $164.28 |
Technical Indicators
Market Signals| Indicator | EXEL | ATR |
|---|---|---|
| Relative Strength Index (RSI) | 52.55 | 76.40 |
| Support Level | $42.57 | $135.99 |
| Resistance Level | $44.15 | $161.98 |
| Average True Range (ATR) | 1.30 | 4.02 |
| MACD | 0.11 | 1.05 |
| Stochastic Oscillator | 80.53 | 99.70 |
Price Performance
Historical ComparisonAbout EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About ATR AptarGroup Inc.
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. Its sales are primarily from Europe (49% of sales) and the United States (28%), with China contributing 5% and other countries contributing 17%. It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.